Pharmacogenetics and interstitial lung disease
Intracellular Signaling Peptides and Proteins
Lung Diseases, Interstitial
Though few pharmacogenetic investigations have been conducted in patients with ILD to date, ample opportunities for pharmacogenetic exploration exist in this patient population. Such exploration will advance our understanding of specific ILDs and help usher in an era of personalized medicine.